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Abstract: 
CNS circuit development requires subcellular control of synapse formation and patterning of 
synapse abundance. Using genetic single-cell analyses, we identified the Drosophila membrane-anchored 
phosphatase “protein of regenerating liver” (Prl-1) as an axon-intrinsic factor that promotes synapse 
formation in a spatially restricted fashion. Loss of Prl-1 in mechanosensory neurons reduced the number 
of CNS pre-synapses that are localized on a single axon collateral and organized as a terminal arbor. 
Homozygous flies lacking all Prl-1 protein had locomotor defects. Overexpression of Prl-1 induced 
ectopic synapses. In mechanosensory neurons Prl-1 modulates the Insulin Receptor (InR) signaling 
pathway within a single contralateral axon compartment thereby affecting the number of synapses. Axon 
branch-specific localization and function of Prl-1 depends on UTR-sequences of the prl-1 mRNA. 
Therefore,  compartmentalized restriction of Prl-1 serves as a specificity factor for subcellular control of 
axonal synaptogenesis.  
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One Sentence Summary: 
Intracellular signaling mechanisms promote synaptogenesis specifically in one subcellular 
compartment of a Drosophila CNS axon. 
 
Main Text: 
Central nervous system (CNS) function relies on controlled axon branching and synapse 
formation during development. Establishment of neuronal circuits requires matching of pre- and post-
synaptic neurons, determination of synapse locations and numbers, and specification of diverse synapse 
types (1, 2). Formation of multiple axon branches allows single CNS neurons to innervate several 
different target areas and target cells thereby increasing output complexity (3, 4). However, for each axon 
branch, the quantity of synapses formed determines the number of potential postsynaptic partners and the 
strength of connectivity to each of them. Branch-specific control of synapse numbers is therefore essential 
for correct and complex circuit formation. While synapses can be formed en passant on primary axon 
branches, formation of terminal arborizations allows for more synapses in a particular location (5). In 
developing axons of both vertebrates and invertebrates, localization of pre-synaptic proteins, as well as 
axonal RNAs and mitochondria, is associated with emergence of filopodial protrusions and their 
stabilization into nascent branches (5-9), including stabilization of arbors by synaptic adhesion complexes 
(10). Thus, terminal arborization and synaptogenesis together lead to formation of local synapse-dense 
axon terminals.  
Cell-surface receptors mediate cell-cell communication and sensing of environmental cues during 
axon guidance, branching, and synapse formation (3, 11-13). For example, “neuritic adhesion complexes” 
containing Neuroligin and Neurexin, and pre-synaptic proteins Syd1 and Liprin-α, locally stabilize 
filopodia establishing distinct axon arborizations (10). Less is known about cell-intrinsic factors that 
locally control terminal arborization and synaptogenesis in vivo (4). Here, we use a genetic single-cell 
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approach in Drosophila to identify a factor that functions in formation of dense, synapse-rich terminal 
arbors specifically in one collateral of a CNS axon. 
We found differences in arborizations and synapse numbers formed by individual axon collaterals 
of single mechanosensory neurons in the Drosophila CNS. We focused on two types of mechanosensory 
neurons that innervate large sensory bristles on the dorsal thorax of the fly (scutellar (SC) and 
dorsocentral (DC) bristles, Fig. 1A). These mechanosensory neurons form three main central axonal 
projections, to innervate anterior, posterior, and contralateral CNS target areas, respectively (Fig. 1B). In 
DC neurons, en passant synapses that form directly on the axon shaft are predominant in the main 
anterior projection, which in addition forms a few variable higher-order processes that sprout from the 
main branch and contain terminal synapses (Fig. 1D). The posterior projection has few terminal or side-
arbors and only forms a few en passant synapses at an intermediate and distal position (Fig. 1D and see 
also (14)). The contralateral projection of DC neurons is rich in both en passant and terminal synapses 
that form on an extensive network of arborizations across the region of the CNS midline and 
contralaterally (Fig. 1D, H). The extensive synaptic arborizations are only present in DC neurons (aDC, 
pDC) and not in the closely related SC mechanosensory neurons, although their target areas overlap 
almost perfectly (Fig. 1B-C). Therefore, mechanosensory neurons provide an in vivo model for studying 
mechanisms underlying the quantitative and subcellular restriction of pre-synapse formation. 
 
Prl-1 function regulates formation of synapse-dense terminal arbors 
Reversible phosphorylation cascades often regulate cellular signal transduction. We therefore 
targeted the kinome / phosphatome of Drosophila to scan for signaling factors that control synaptogenic 
regulatory mechanisms. RNAi constructs (15) were driven in a restricted set of peripheral 
mechanosensory neurons as described (see Experimental Procedures and (14)). We assessed phenotypes 
caused by cell-autonomous depletion of the target gene products in mechanosensory neurons. Among a 
set of synaptogenic candidates we found that knockdown of phosphatase of regenerating liver (prl-1) 
eliminated the terminal arbor and  reduced  numbers of synapses in the contralateral projecting axon 
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collateral (Fig. 1E, I), while en passant synapses along the axon shaft, and synapses in the other two main 
axon collaterals, were unaffected (Fig. 1E, I). Terminal arbor and bouton formation at Drosophila 
neuromuscular junctions appeared unaffected (see Fig. S8). The Drosophila genome encodes a single prl 
gene; three Prl genes (Prl-1-3) are found in vertebrates (16, 17). We generated prl-1 loss-of-function 
alleles by CRISPR/Cas9-mediated gene editing. In six mutant alleles (Fig. S1A, B) the stop codons are 
close to the start ATG and no Prl-1 protein can be detected by antibody staining (Fig. S1C). We consider 
these six alleles to be protein null mutants. prl-1 null flies are viable and fertile, albeit hatching is delayed 
(Fig. S1D). Consistent with the RNAi knock-down, synaptic arborizations were lost from the contralateral 
mechanosensory neuron axon collateral in prl-1 mutant animals (Fig. 1F, J, M, N). Neither cell body 
morphology, axon caliber (Fig. S3), nor axon growth and guidance to the CNS were affected. Projections 
of the related SC mechanosensory neurons were normal (Fig. S4). The DC neuron mutant phenotype was 
fully rescued by introduction of a prl-1 BAC transgene (bacterial artificial chromosome; Fig. 1G, K). 
Anterior and posterior branches of the mechanosensory neuron arbor did not show any morphological 
defects in the mutants, indicating that prl-1 is specifically required for formation of dense synaptic 
terminal arborizations in one out of three main mechanosensory neuron axon collaterals. We estimated 
numbers of pre-synaptic active zones by quantifying puncta of the active zone marker Bruchpilot (Brp; 
(18, 19)), and found an approximate decrease by 65% of synapses in the contralateral branch, while 
synapse numbers were not altered in the anterior branch (Fig. 1O, P; Fig. S5). Consistent with a role for 
Prl-1 in only the axon compartment of the contralateral branch, HA-tagged transgenic Prl-1 specifically 
expressed in DC neurons is enriched in this axon collateral compartment (Fig. 1Q). Correlative light and 
electron microscopy confirmed labelling of pre-synapses by the markers (see also (14)). No defects were 
apparent in the structure of remaining synapses in the mutant (Fig. S6). 
 Homozygous prl-1 mutant adults are normal in size and morphology (Fig. S1E,F), but 
occasionally show a “held-up” wing phenotype (see Movie S1). The mutant flies however display 
locomotor defects and cannot fly (Fig. S7A-C; Movie S1). Our analysis of the morphology of NMJ 
synapses shows no defect, suggesting that prl-1 is not required for NMJ formation (Fig. S8). In contrast, 
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analysis of the brain and CNS revealed altered synaptic connectivity in several circuits in homozygous 
prl-1 mutant flies (Fig. S7, S9, S10). First, two distinct brain neuropils related to olfaction and olfactory 
related learning, the antennal lobes and mushroom bodies, respectively, were disorganized, with evident 
axonal or synaptic defects (Fig. S7E, G, and Fig. S9). For example, we find changes in size and 
organization of synaptic termination zones of odorant receptor neurons in their respective target area, the 
glomeruli of the antennal lobe (Fig. S7E, G, I). Second, while cell numbers of the sensory neurons (Fig. 
S7D, F, H) as well as neurons of the ventral nerve cord (VNC; Fig. S10D, E) are unaltered, the size of the 
CNS neuropile (i.e. region of densely packed axons, dendrites, synapses) is reduced in prl-1 homozygous 
adult flies (Fig. S10A-C). We noted a size reduction particularly of the metathoracic neuropile in the 
VNC, which is smaller in homo- or hemizygous prl-1 null mutants than in wild-type flies or prl-1 null 
mutants rescued with the BAC transgene. 
To test if an increase of Prl-1 function (i.e. gain-of-function) could promote ectopic synapse 
formation, we overexpressed Prl-1 in mechanosensory neurons, in otherwise wild-type animals (Fig. 2). 
Indeed, we found an aberrant increase in Syt1 puncta in ectopic proximal regions of the main axon, a 
region that rarely contains pre-synapses in controls (Fig. 2A, B, E-H). In addition, axon terminals of Prl-1 
overexpressing neurons appeared less mature than controls, and resembled axonal protrusions occurring 
during synapse formation at developing stages (see Fig. 5). Small protrusions were observed on the main 
branch (Fig. 2F), and even longer ones in terminal regions (Fig. 2D). These filopodial protrusions cannot 
be detected in control samples (Fig. 2C, E). Ectopic protrusions were associated with Syt1 marker puncta, 
which were located either at the base or within the protrusion (Fig. 2F’’). These findings suggest that Prl-
1 is capable of inducing ectopic synapses. However, an increase of synapses is not seen throughout the 
entire axonal arbor indicating constraints in the synaptogenic function of Prl-1. Formation of ectopic 
synapses by gain of Prl-1 is not linked to an increase in ectopic branches or terminal arbors. This suggests 
the possibility that Prl-1 is involved in synapse formation or stabilization, rather than terminal arbor 
formation (i.e branching). 
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Prl-1 function involves modulation of Insulin Receptor (InR) to Akt signaling 
In our attempts to identify regulators or targets of Prl-1 phosphatase, we conducted a secondary 
candidate screen and discovered that cell-autonomous inhibition of multiple Insulin Receptor (InR) 
signaling components resulted in prl-1 like phenotypes (Fig. 3). RNAi-based knock-down of InR in 
mechanosensory neurons, or expression of a dominant negative form of the InR, led to pronounced 
reduction of terminal synapses on the contralateral axon compartment of DC neurons (Fig. 3B, top 
panels). The same was observed for knockdown of Chico (encoding a Drosophila InR substrate), of PI3 
kinase (by targeting either the p110 or the p60 subunit), of Akt, and of the mTORC1 complex subunit 
Raptor (Fig. 3B, D, E; Fig. S11; Fig. S12). Consistent with the finding that knockdown of PTEN, a 
negative regulator of the pathway, increases terminal synaptic arborizations on the contralateral branch, 
expression of a membrane-targeted, constitutively active form of Akt (20) led to hypertrophy of synaptic 
terminals (Fig. 3A, B, D). We also tested knock-down of Pdk but found no synaptic defect, suggesting 
that Pdk does not participate in this presynaptic signaling cascade (Fig. S13). All the above-mentioned 
manipulations affected the contralateral projecting axon collateral but not the main axon shaft or other 
collaterals of DC neurons (Fig. 3A; Fig. S12). 
As loss of prl-1 leads to the same loss of terminal synapses as reduction in InR/Akt signaling, we 
performed three experiments to test for genetic interactions and epistasis. First, we knocked down PTEN 
in prl-1 heterozygous mutant animals and observed a suppression in exuberant arborizations observed 
upon PTEN knockdown alone (Fig. 3C, D; Fig. S11; Fig. S12). Second, we expressed constitutively 
active Akt in mechanosensory neurons of prl-1 null animals. This led to a rescue of terminal synapses in 
the contralateral branch (Fig. 3C, D, Fig. S11; Fig. S12). Third, and conversely, we tested whether loss of 
Akt retained dominant defects over UAS-Prl-1 expression. UAS-Prl-1 expression showed no rescuing 
effect in mechanosensory neurons depleted of Akt (Fig. 3D), consistent with Akt being downstream of 
Prl-1. 
All our genetic studies are also consistent with previous findings of high-throughput screens 
targeting the kinase/phosphatase signaling networks in vitro. Combined genome-wide RNAi and 
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proteomics screens in Drosophila cells suggested that activity of Prl phosphatases might be linked to InR 
signaling (21), and several vertebrate cell-culture studies provided evidence for a role of Prl phosphatases 
in PI3K – PTEN / Akt signaling (22, 23). 
Thus we suggest that compartmentalized prl-1 activity regulates a spatially specific mode of 
synaptogenesis in terminal arbors via modulation of the InR pathway likely upstream of Akt. 
 
Targeting phosphoinositide levels affects terminal arbors 
Prl phosphatases have various potential protein targets such as the ERM protein Ezrin or a Rho-
GTPase-activating protein (16), although RNAi based knock-down of several proposed protein targets 
provided no evidence of their involvement in Prl-1-related functions in synapse formation (Fig. S14). 
Vertebrate Prl phosphatases can dephosphorylate phospholipids in vitro: human Prl-3 has a PI(4,5)P2 
(phosphatidylinositol 4,5-bisphosphate) 5-phosphatase activity, dephosphorylating PI(4,5)P2 to PI(4)P 
(phosphatidylinositol 4-phosphate) (24). Moreover, phospholipids directly regulate Akt signaling (Fig. 
3E). Akt is recruited to the plasma membrane and activated by PI(3,4,5)-trisphosphate and PI(3,4)P2 (25, 
26). PTEN is itself activated by PI(4,5)P2 (27).  
We therefore tested whether dephosphorylation of PI(4,5)P2 could be relevant in vivo during 
synapse formation of DC neurons. We reasoned that a loss of Prl-1 activity could cause an increase of 
local PI(4,5)P2 levels and that an increase of PI(4,5)P2 levels in DC neurons could also be achieved by 
promoting phosphorylation of PI(4)P by a PI(4)P specific kinase. The Drosophila PI(4)P 5-kinase Skittles 
(Sktl) catalyzes PI(4)P phosphorylation to PI(4,5)P2 (28-30). Therefore, Sktl overexpression in DC 
neurons might be equivalent to loss of Prl-1. We found that Sktl overexpression in DC neurons leads to a 
reduction of terminal arborizations, phenocopying prl-1 loss-of-function (Fig. 4A-C). Moreover, co-
expression of Prl-1 together with Sktl suppresses the Sktl gain-of-function phenotype (Fig. 4A,C). This 
result provides support for the idea that the Prl-1 phosphatase and Sktl kinase can carry out opposing 
functions and is consistent with the hypothesis that PI(4,5)P2 levels could be decreased by Prl-1 function 
in vivo. 
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In amino acid sequence, Drosophila Prl-1 shares features with human Prl-3 that are thought to 
affect activity toward phosphoinositides (Fig. S15). The point mutation G129E in human PTEN and the 
mutation A111S in human Prl-3 abolish phosphatase activity toward phosphoinositides, but not toward 
phosphoproteins, of these related phosphatases (24, 31). We, therefore, generated transgenes with the 
corresponding mutants in Drosophila Prl-1 (G114E and A116S, respectively), and tested their ability to 
rescue the prl-1 null phenotype in DC neurons. While a mechanosensory neuron specific expression of a 
wild-type transgene rescued the loss of terminal arborizations (Fig. 4D,E), the G114E mutant transgene 
did not (Fig. 4D,E; Fig. S16).  In this experiment only mechanosensory neurons express the rescue 
constructs and the VNC target tissue remains mutant with reduced neuropile size (Supplementary Fig. 
S16). In the case of the A116S mutant, we were unable to observe axonal projections of labeled 
mechanosensory neuron clones, suggesting a dominant effect of this mutant transgene that prevents axon 
growth or induces apoptosis or axon degeneration. 
To further substantiate that Prl-1 leads to dephosphorylation of PI(4,5)P2 in vivo, and to 
determine whether synapse loss in mechanosensory neurons of prl-1 null mutants is due to increased 
PI(4,5)P2 levels, or, conversely, decreased PI(4)P levels, we used constructs expressing the PH domain of 
phospholipase Cd fused to GFP (PLCdPH.GFP (32)). PLCdPH.GFP binds to PI(4,5)P2 and prevents 
interactions of PI(4,5)P2 with cellular binding partners, thereby reducing functional PI(4,5)P2 levels (33). 
Expression of PLCdPH.GFP, but not of a mutant form that does not bind to PI(4,5)P2 (32), rescued loss 
of terminal arborizations in prl-1 mutants (Fig. 4F-H). We therefore conclude that the prl-1 null 
phenotype is a consequence of elevated PI(4,5)P2 in the mutant, and that PLCdPH.GFP expression can 
restore terminal synapse formation by blocking excessive PI(4,5)P2. 
Together, our results provide evidence that Prl-1 promotes DC neuron axon arborization in a 
specific target area by locally influencing the phosphoinositide-dependent PI3K-PTEN signaling loop. 
 
Prl-1 affects synapse stabilization 
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To gain insights into the cellular processes that cause reduced terminal synapse and arbor 
formation specifically in one target area of mechanosensory neurons in prl-1 null flies, we visualized the 
cellular differentiation of single DC neuron compartments during development (Fig. 5). In wild-type flies, 
we identified three distinct stages of terminal arbor and synapse formation. In a first phase (45-70 hrs 
after pupariation, apf), the contralateral growing axon collateral extends many filopodial protrusions in all 
directions including the growth direction. All these protrusions extend from the main axon shaft (Fig. 5A, 
top left) but are most prominently formed on the contralateral projecting axon collateral. In a second 
phase (60 – 75 hrs apf), in which the main branch has reached the contralateral target area, filopodial 
protrusions are most numerous at an axon segment stretching across the midline. At this stage, new 
cellular processes that contain Syt1 marker protein have formed and contain additional filopodia 
protrusions (Fig. 5A middle left, 5C middle and bottom; Fig. S18A). These satellite growth cones (34) are 
likely precursors of terminal synapse-bearing arborizations observed in adult animals. Finally, in a third 
phase (after 75 hrs apf), immature filopodial protrusions and satellite growth cones disappear, and are 
transformed into terminal synapse-bearing arbors (Fig. 5A, bottom left panel; Fig. S18B). In prl-1 null 
flies in stage 1 and in part in stage 2, the developing axon collaterals and filopodial protrusions form like 
in wild type controls (Fig. 5A, top right panels). Filopodial protrusions are extending into different 
directions in normal abundance (Fig. 5B, left plot). Likewise, satellite growth cones with filopodia, some 
of which having Syt1-positive puncta, are also formed in prl-1 mutants, and filopodia originate from them 
(Fig. 5D; Fig. S18A). However, the number of satellite growth cones per axon segment is reduced in 
mutant animals, and satellite growth cones extend less filopodial protrusions, both leading to a net 
reduction in the total number of filopodial protrusions (Fig. 5B). In contrast to a reduction of filopodia 
originating from satellite growth cones, we did not observe a reduction of filopodia emanating from the 
main branch (Fig. 5B, right panels). These results indicate that early stages of arborization at the midline, 
i.e. formation of filopodial protrusions and satellite growth cones, is not affected upon loss of prl-1. In 
contrast, formation or stabilization (or both) of a sufficient amount of satellite growth cones, is defective 
in prl-1 mutants. Because Syt1 marker accumulates in satellite growth cones, and filopodia extend from 
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Syt1 positive locations, these processes could be dependent on accumulation of synaptic material or 
formation of synapses in emerging axonal processes. Finally, in stage 3 in prl-1 mutant axons most of the 
protrusions and satellite growth cones have disappeared. This suggests that in prl-1 mutants stabilization 
or consolidation of the terminal arbors as well as nascent synapses failed and are being aberrantly 
retracted (Fig. 5; Fig. S18B). Thus Prl-1 function is necessary for stabilization or maturation of terminal 
synapse-bearing arbors but not initiation or branching of axons at terminal arbors. 
 
Compartment-specific Prl-1 enrichment  
How does signaling by Prl-1 and the InR / Akt signaling activity get spatially restricted in DC 
axons? The branched morphologies of neurons bring many opportunities to compartmentalize subsections 
of the neuron. For mechanosensory neurons additional genetic screens and characterization of other 
molecular pathways are required to study relevant mechanisms. However, by studying the localization of 
Prl-1 protein in mechanosensory neurons itself we found that (i) epitope-tagged Prl-1 expressed from a 
transgene is enriched in the contralateral axon collateral, and also present to a lesser degree in midline-
proximal branches (see above, Fig. 1Q). (ii) the subcellular localization as well as the rescuing activity are 
dependent on regulatory sequences in long 5’- and 3’- untranslated regions (UTRs) of prl-1 messenger 
RNAs (Fig. S19). These long UTRs are essential for Prl-1 function in local synaptic arbor formation as 
only HA-tagged Prl-1 proteins expressed from a transgene containing both the 5’- and 3’-UTRs (HA.prl-
1.UTRsplus) were able to substantially rescue synaptic defects of prl-1 mutant neurons (Fig. 6F; Fig. S16). 
Anti-HA stainings showed that the epitope tagged protein localized to distal axons of mechanosensory 
neurons and was enriched in contralateral projecting branches (Fig. 6B,D; Fig. S20). In contrast, a 
transgene without UTRs (HA.prl-1.UTRsminus) led to weaker Prl-1 signal in mechanosensory neuron axons 
in the CNS  (Fig. 6B; Fig. S20). Nevertheless, without UTRs, the compartmentalized enrichment of Prl-1 
is still visible in wildtype or heterozygous neurons (Fig. 6B,C). Given that Prl proteins form homotrimers 
(35, 36) we reasoned that formation of complexes between Prl-1 expressed from the endogenous locus, 
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and HA.Prl-1 expressed from transgenes, could lead to a trapping of HA.Prl-1 protein at sites of 
endogenous Prl-1 enrichment (see schematic, Fig. 6E). Indeed, we found that the contralateral branch 
enrichment of protein expressed from HA.prl-1.UTRsminus was lost in a prl-1 null mutant background, and 
HA.Prl-1 localized ectopically and evenly to all axon branches of mechanosensory neurons (Fig. 6B,C). 
In contrast, localization of HA.Prl-1 expressed from the transgene with UTRs remained 
compartmentalized even in the absence of endogenous protein (Fig. 6B,D). Comparisons of protein levels 
in diverse wild type and mutant backgrounds by use of fluorescent intensity is challenging. It is further 
complicated by the reduction of axon arbors in mutant and partially rescued samples, which thereby could 
indirectly contribute to a reduced fluorescence intensity. However, the fact that in null mutants the 
HA.prl-1 protein (when expressed from transgene lacking UTRs, i.e. HA.prl-1.UTRsminus) is redistributed 
ectopically and thereby leads to an increased intensity in ipsilateral axon collaterals (unaffected in 
mutants), and lack of changes in distribution of the general membrane marker CD8.Cherry in mutants 
(Fig. S21), provide clear evidence that Prl-1 is endogenously enriched in the contralateral projecting axon 
of pDC axons. Consistent with its role in formation of terminal arbor synapses, a tagged InR protein was 
also localized to the contralateral projecting pDC collateral at mid-developmental stages (Fig. S22). 
Collectively, these results reveal a role of the prl-1 UTRs in axon compartment specific 
localization of the Prl-1 protein and that this subcellular enrichment is likely essential for the functional 
specificity of Prl-1 in neurons. 
 
Concluding remarks 
Here we identified cell-intrinsic presynaptic mechanisms that contribute to subcellular control of 
synapse type and numbers in Drosophila CNS axons. Compartment-specific regulation of the InR 
signaling by Prl-1, likely by targeting the PI3K-PTEN-dependent phosphoinositide cycle, enables the 
spatially restricted formation of a synapse-rich terminal arbor. This is supported by several 
complementary experiments. First, genetic interactions show that loss of a single copy of prl-1 can 
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suppress PTEN knock-down dependent synapse defects (Fig. 3; Fig. S11). Second the genetic epistasis 
analysis, where activated Akt can rescue prl-1 mutant defects but not vice versa, suggests that Prl-1 
functions upstream of Akt (Fig. 3D; Fig. S11). Third, the targeted manipulation of PI(4,5)P2 levels by 
overexpressing the PI(4)P 5-kinase Skittles in mechanosensory axons phenocopies loss of Prl-1 (Fig. 4A-
C). Fourth, reducing the level of accessible PI(4,5)P2 by expressing a PI(4,5)P2 specific binding domain 
(PLCdPH.GFP) can suppress the Prl-1 synapse formation defects (Fig. 4F-H). All these experiments are 
consistent with the model that Prl-1 targets the PIP2 levels in presynaptic axon segments. However, we 
cannot rule out that Prl-1 might only indirectly lead to dephosphorylation of PI(4,5)P2 through an as of 
yet unknown target in neurons. Nevertheless, this study shows that distinct lipid/phosphoinositide 
domains in developing axons and their likely dynamic changes contribute to spatial specificity of CNS 
synapse formation. 
While enrichment of Prl-1 protein and activity in a distinct axon branch defines this 
compartmentalization, it is unclear whether the localized enrichment is due to protein trafficking, protein 
retention, or local translation. We consider local translation a particularly attractive scenario because our 
data showed that the UTR sequences of prl-1 mRNA are functionally required. Moreover, the InR 
pathway, which is affected by Prl-1, itself is a potent regulator of translation (37). The identification of 
regulatory UTR sequences in the prl-1 mRNA that direct axon branch specific protein localization will be 
a decisive tool for future studies in order to define the responsible cellular mechanisms. 
Vertebrate Prl-1-3 phosphatases affect cell division or growth as well as metastasis of tumor cells (17, 38, 
39). Analogous to Drosophila Prl-1, the expression of vertebrate Prl-3 in cancer cell lines is regulated at 
the translational level through the RNA-binding protein PCBP1 and a GC-rich motif in the 5’UTR of the 
prl-3 mRNA (40). However, roles for Prl proteins in CNS development have not been reported. Yet Prl-1, 
Prl-2, and Prl-3 are broadly expressed in the vertebrate CNS (Allen Brain Atlas (41)). Prl phosphatases 
are therefore poised to function in vertebrate brain development in ways similar to the effects we have 
shown here on assembly of neuronal circuits and synapses in Drosophila. 
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Figure 1. Loss of prl-1 disrupts formation of synapse-dense terminal arbors specifically in one axon 
collateral. (A) Location of posterior Dorsocentral (pDC) and anterior Scutellar (aSC) large bristles on the 
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fly thorax. (B) Central axon projections of mechanosensory neurons innervating the pDC and aSC 
bristles, respectively, in the adult animal. Boxes indicate a central region of the contralateral collateral 
(see C). Top, anterior; bottom, posterior in this and all subsequent figures. (C) The DC axon collateral 
that projects to the contralateral side of the CNS has formed dense terminal arborizations, while the same 
axon collateral of the SC neuron has not (arrows). (D) Axon (CD8.GFP, red) and pre-synapse 
(Cherry.Syt1, Synaptotagmin-1, green) markers expressed in a single DC neuron and visualized by 
immunostaining. Neural Cadherin (NCad, blue) is used for neuropil staining. Three primary axon 
collaterals innervate distinct areas of the CNS (1, anterior; 2, contralateral; 3, posterior) with different 
amounts of synapses. Note the extensive Syt1 labelling in the terminal arbors of the contralateral axon 
branch (arrow). (E) DC neuron, in which prl-1 was knocked down by RNAi. Terminal arbors are strongly 
reduced / virtually absent in the contralateral branch (arrow), while the two collaterals that innervate the 
other main target areas are unaffected. (F) Terminal arbors are completely lost from the contralateral 
branch in a whole-animal prl-1 mutant (arrow), while the other target areas are unaffected. (G) The arbor 
loss phenotype is rescued by introduction of a transgenic bacterial artificial chromosome (BAC) 
containing prl-1. (H-K) Magnification of the DC neuron contralateral axon collateral in indicated 
genotypes, illustrating loss of terminal synaptic arborizations upon prl-1 knockdown or loss-of-function 
(I, J). CD8.GFP and Cherry.Syt1 signals are reconstructed with Imaris software for panels H’’-K. (L,M) 
Schematics illustrating the three target areas innervated by the main axon collaterals of mechanosensory 
neurons, the differential amounts and types of synapses formed, and the loss of synaptic arborizations in 
prl-1 null animals (arrows). (N) The territory occupied by terminal arbors on the contralateral branch is 
strongly reduced in different whole-animal prl-1 mutant combinations (ns/Df, nonsense mutation over 
deficiency; ms, missense mutation, see Fig. S1 for the mutations and Fig. S2 for the quantification 
method). a.u., arbitrary units; n.s., non significant. *, p<0.05, Kruskal-Wallis test with multiple 
comparisons. (O) Synapse numbers, as assessed by counting puncta of the Brpshort.GFP marker (42) 
expressed in single DC neurons are significantly decreased in the contralateral branch upon loss of prl-1 
(Mann-Whitney test, p<0.0001; see Fig. S5 for examples images of samples used for quantification). (P) 
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Synapse numbers are not altered in the anterior target area 1 upon loss of prl-1 (Mann-Whitney test, n.s., 
non significant). (Q) HA-tagged Prl-1 protein is enriched in contralateral axon collaterals of DC neurons 
(false-color intensity display; blue, low levels; yellow-red, high levels). Scale bars: B, 50 µm; D & Q, 20 
µm; H, 10 µm. In the graphs of this and all subsequent figures, individual measured values and mean are 
displayed, and error bars indicate standard deviation. Genotypes for all panels can be found in Table S1. 
  
Submitted Manuscript: Confidential 
23 
 
Figure 2. Prl-1 overexpression induces ectopic synaptic marker accumulation and immature axonal 
protrusions. (A) Proximal regions (arrowheads, magnified in inset) of central mechanosensory neuron 
projections contain few Syt1 marker puncta in control animals. (B) Syt1 marker accumulates in proximal 
axon projections in Prl-1 overexpressing (OE) animals (arrowheads; inset). (C) Morphology of a mature 
contralateral mechanosensory neuron projection in an adult control animal. Arrow in C’’ (magnification) 
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indicates a terminal branch. (D) In adult animals overexpressing Prl-1 in mechanosensory neurons, the 
contralateral axon collateral has a less mature morphology, with small filopodial protrusions along the 
branch, and large protrusions at its distal end (arrowheads D’’). (E) The proximal region of the central 
axonal projection contains only few Syt1 marker puncta in controls (see region outlined in red in E’). (F) 
Syt1 puncta are more numerous upon overexpression of Prl-1 in mechanosensory neurons (proximal axon 
projection region outlined in F’). Arrowheads in F’’ indicate small immature protrusions from the main 
axon shaft. (G, H) Quantification of Syt1 puncta density (G) and area filled by Syt1 puncta (H) in the 
proximal axon projection of control and Prl-1-overexpressing (OE) mechanosensory neurons. *, p<0.05; 
**, p<0.01, Mann-Whitney test. Scale bars: A, 20 µm; C, 10 µm. 
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Figure 3. The Insulin Receptor signaling pathway controls formation of synapse-dense terminal arbors 
and interacts with prl-1. (A) Whole CNS projections of control DC neurons and DC neurons with reduced 
(Akt RNAi) or enhanced (PTEN RNAi; Akt constitutively active, CA) Akt signaling. Note drastic 
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reduction (Akt RNAi) and increase (PTEN RNAi; Akt CA), respectively, of synaptic terminal arbors in 
the contralateral branch (target area 2), while the other axon collaterals are unaffected (such as target area 
1; note that the anterior contralateral projection, here present only in the RNAi samples, is variable also in 
wild-type flies). (B) Morphology of the contralateral axon branch upon indicated manipulations in 
mechanosensory neurons. Visualizations of the CD8.GFP axonal marker (red) and Cherry.Syt1 pre-
synaptic marker (green) are shown. (C) Reduction of Prl-1 levels suppresses the PTEN phenotype (top), 
while activation of the Akt signaling pathway rescues the prl-1 null phenotype (bottom, middle, 
respectively). Note that Akt CA was expressed only in mechanosensory neurons, which target into a small 
CNS (see Fig. S12). (D) Quantification of terminal arbor territory in the indicated genotypes. Standard 
deviation of controls is shaded in gray. Manipulations reducing activity of the InR/Akt signaling pathway 
are displayed in dark blue, manipulations enhancing the activity of the pathway are in light blue. Effects 
of co-expressing Akt RNAi with CD8.Cherry and Prl-1, respectively (last two columns of graph) were 
assessed by dye-fills and not with genetic labelling as for the rest of the genotypes. n.s., non significant; 
**, p<0.01; ***, p<0.001, ordinary one-way Anova with multiple comparisons. (E) Schematic of 
InR/Akt/mTORC1 signaling. Positive components are shaded in dark blue, the inhibitor PTEN is in light 
blue. Changes in mechanosensory neuron terminal arbor territory upon manipulation of the gene products 
are indicated by arrows. KD, knockdown; DN, dominant negative; CA, expression of constitutively 
active. PI, phosphatidylinositol; PIP2, PI(4,5)-bisphosphate; PIP3, PI(3,4,5)-trisphosphate. Scale bars: A, 
20 µm; B, 5 µm. 
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Figure 4. Genetically targeting phosphoinositide levels controls terminal arbor formation. (A) Original 
data and visualizations for examples of DC neuron contralateral branches in animals of the indicated 
genotypes. Axons were filled with a fluorescent lipophilic dye. Arrowhead points to terminal branches 
that are lost in prl-1 null animals and upon overexpression (OE) of Sktl in mechanosensory neurons, but 
restored upon co-overexpression of Prl-1 with Sktl. (B) Sktl overexpression phenotype (right panels) in a 
mechanosensory neuron labelled genetically with CD8 axonal and Syt1 pre-synaptic markers. Note the 
reduction of terminal arbor synapses. (C) Quantification of terminal arbor territory for Sktl and Prl-1 
overexpression. *, p<0.05; **, p<0.01; Kruskal-Wallis test. (D) Visualizations for examples of 
mechanosensory neuron contralateral collaterals in animals of the indicated genotypes. Expression in 
mechanosensory neurons of a wild-type (wt) prl-1 transgene with 5’- and 3’-UTRs rescues terminal 
arbors, while expression of a UTR-containing prl-1 transgene with the G114E mutation does not. Note 
that mechanosensory neurons project into a VNC of reduced size (Fig. S16). Defects in the target area are 
therefore likely preventing full rescue of terminal arborizations and synapses to wild-type levels (see also 
panels E, G and Fig. 6F).  (E) Quantification of terminal arbor territory in prl-1 null flies rescued with 
different prl-1 transgenes as in D. See also Fig. 6 for more examples of rescue with a wild-type prl-1 
transgene. Data of prl-1 -/- flies is replotted from Fig. 3D. *, p<0.05; Mann-Whitney test. (F) 
Visualizations of dye-filled contralateral axonal projections in animals of indicated genotypes. Expression 
of the PH domain of PLCd (PLCdPH.GFP) in mechanosensory neurons rescues terminal arborization loss 
in prl-1 mutant animals (see also Fig. S17 for PLCdPH.GFP expression in mechanosensory neurons). 
Expression of a mutant PLCd PH domain (PLCdPH[R40L]) that does not bind to PI(4,5)P2 does not 
rescue the prl-1 phenotype. (G) Quantification of terminal arbor territory of dye-filled contralateral 
collaterals in animals of genotypes as in F. *, p<0.05; ***, p<0.0001; ordinary one-way Anova with 
multiple comparisons. (H) Single-cell expression of PLCdPH.GFP wild-type and [R40L] mutant, 
respectively, in mechanosensory neurons. CD8.Cherry is co-expressed as an axon marker, and Cherry and 
GFP fluorescence were imaged. Expression of wild-type PLCdPH.GFP cell-autonomously rescues the 
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loss of terminal arborizations in prl-1 null mutant animals, but PLCdPH.GFP [R40L] does not. Note that 
PLCdPH.GFP wild-type can be found at higher levels in the axon than the [R40L] mutant marker protein 
(see also Fig. S17 for PLCdPH.GFP wt localization in axons). (I) Schematic placing Prl-1 in the context 
of InR / Akt signaling and control of PIP levels based on the identified genetic interactions. All scale bars 
represent 10 µm. 
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Figure 5. Prl-1 promotes consolidation of terminal arbors and nascent synapses. (A) Successive 
developmental stages of the contralateral DC neuron axon collateral in fixed control and prl-1 null 
samples. In an early phase (top left, sample around 47 hrs after puparium formation, apf), developing 
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branches extend long filopodial protrusions (arrowheads) and grow towards the contralateral side of the 
CNS. At mid-stages (middle left, around 72 hrs apf), filopodia-rich satellite growth cones are visible (see 
C and also Fig. S18A, arrowheads). At late stages (bottom left, around 90 hrs apf), filopodia and satellite 
growth cones have disappeared, and terminal arbors have consolidated. In prl-1 null animals (right 
panels), filopodia and satellite growth cones are initially formed, but fail to accumulate and be 
consolidated on the contralateral branch. Note that CNS development is delayed by approximately 5-10 
hrs in the mutant at these stages. Corresponding developmental stages assessed by branch growth 
progression, rather than by absolute timing, are displayed. Magnified panels show examples of filopodia 
morphology. (B) Quantification of filopodia and satellite growth cones during different developmental 
stages (left panels) and at mid-stages of collateral branch formation (right panels). n.s., non significant, *, 
p<0.05, **, p<0.01, Mann-Whitney test. n.s./*: approximate p-value 0.06, computed exact p-value 0.048. 
(C) Co-labelling of axon and Synaptotagmin1 pre-synaptic marker in wild-type developing contralateral 
collaterals. White arrowheads indicate Syt1 accumulation on the main axon shaft, at sites where filopodia 
sprout. Blue arrowheads point to satellite growth cones, which are devoid of Syt1 signal at an early stage 
(top panels). Syt1 starts to localize to satellite growth cones at a slightly later developmental stage 
(middle panels). (D) prl-1 mutant animal. Syt1 localizes to sites of filopodia sprouting (white arrowheads) 
and to satellite growth cones (blue arrowheads) at this early stage. Scale bars: 10 µm & 2.5 µm (insets). 
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Figure 6. prl-1 UTRs are essential for axon localization and function. (A) Schematic illustrating the 
expression pattern of pnr-gal4 (red) in adult flies, which was used for driving UAS constructs in the 
experiment shown in (B). pnr-gal4 is active in the mechanosensory neurons innervating the 8 large 
bristles (DC and SC macrochaetae) and all the small bristles (microchaetae) located in the central domain 
of the thorax (top, not to scale). The composite of the CNS axon projections of these neurons results in 
the bilateral symmetric pattern shown below; numbering of projections corresponds to the numbering at 
single-axon resolution in panel E and in Fig. 1D,L.  (B) mechanosensory neuron expression of prl-1 
transgenes with and without UTRs, respectively, detected by antibodies against Prl-1 and against the HA 
epitope tag, respectively. Anti-Prl-1 staining is visible in CNS axon projections only when expressing Prl-
1 from a transgene with UTRs. Prl-1 protein expressed from this transgene is readily detected by staining 
against the HA tag in mechanosensory neuron axon projections in the CNS (top panels; note panels 
showing data recorded with low and high gain, respectively, as labelled below), and is enriched in the 
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contralateral branches (blue arrowheads) both in presence (left panels) and absence (right panels) of 
endogenous Prl-1. In contrast, Prl-1 expressed from a transgene without UTRs (bottom panels) is 
expressed at much lower levels in mechanosensory neuron central axon projections (only visible when 
imaged with high gain), and its enrichment in the contralateral branch (blue arrowheads) strongly depends 
on endogenously expressed Prl-1. Yellow arrows point to proximal regions of the mechanosensory 
neuron central projections, for direct comparison between panels. Panels on the right show high 
magnification details of HA staining in the proximal regions (top, framed in yellow) and in the 
contralateral branches (bottom, framed in blue). Note that signal is stronger in contralateral regions for all 
genotypes except for HA.Prl-1 expression from a construct without UTRs in prl-1 -/- animals. Scale bars: 
50 µm main panels, 2 µm magnification panels. (C) Fluorescent signal quantification of HA.Prl-1 
expressed from the transgene without UTRs, in a region of interest (ROI) on the contralateral branches 
(corresponding to magnification panels in B) relative to an ROI of the same size on a proximal CNS 
segment of the axons (magnification panels in B). The enrichment on the contralateral branches is 
strongly reduced in animals without endogenously expressed Prl-1. **, p<0.01, Mann-Whitney test. (D) 
Same fluorescent signal quantification as in C, for constructs with UTRs, reveals no significant (n.s., 
Mann-Whitney test) difference in the presence or absence of endogenously expressed Prl-1. Note that this 
construct is expressed at much higher levels than the construct without UTRs (see B), which is however 
not reflected here as relative values are displayed. See also Fig. S21 for quantification of the membrane 
marker CD8.Cherry in wild-type and prl-1 -/- animals. (E) Schematic illustrating formation of 
heterotrimers between Prl-1 expressed from the endogenous locus and HA-tagged Prl-1 expressed from 
the transgene without UTRs, leading to enrichment of HA.Prl-1 in the contralateral branch (left). In the 
absence of endogenous Prl-1, HA.Prl-1 expressed from the transgene without UTRs is not enriched in the 
contralateral branch (middle). HA.Prl-1 expressed from a transgene with UTRs, however, is still enriched 
in the contralateral branch even in the absence of endogenous Prl-1 (right), albeit it also accumulates in 
the anterior branch, possibly due to over-expression of the protein. (F) Quantification of contralateral 
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projection arbor territory reveals that loss of arbors cannot be rescued by a prl-1 transgene without UTRs 
(see also Fig. S16). *, p<0.05, Mann-Whitney test. 
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Materials and Methods 
Cloning of constructs 
For cloning the HA-tagged prl-1 CDS construct without UTRs, the prl-1 coding sequence was 
obtained from cDNA of Canton S wild-type flies as follows: RNA was extracted from 15 whole 
female adults using TRIzolTM Plus RNA Purification Kit (ThermoFisher Scientific, catalog 
#12183555) and reverse transcribed using iScriptTM cDNA Synthesis Kit (Bio-Rad, catalog 
#1708890). The prl-1 CDS was then PCR-amplified using the 
primers TGCTCTAGAGGAATGAGCATCACCATGCGTC 
and TGCTCTAGACTATTGCACAGAACATGAATTC, and cloned into pUASTattB (43) with 
XbaI. For insertion of a single HA-tag coding sequence at the 5’-end of the prl-1 CDS, the 
plasmid was amplified using primers 
CGGGGTACCATGTACCCCTACGACGTGCCCGACTACGCCGGATC 
GGGAATGAGCATCACCATGCGTC and CGGCGGGGTACCCTCGAGCCGCGGC, 
followed by KpnI digestion and self-ligation of the amplification product. For cloning prl-1 
constructs with UTRs, the prl-1 cDNA corresponding to the RB isoform (flybase.org) was 
obtained from the plasmid pFLC1-prl-1RB (clone #RE55984, the Drosophila Genomics 
Resource Center, Indiana University). prl-1RB was subcloned from pFLC1-prl-1RB into 
pUASTattB (43) as a NotI / KpnI fragment. For the constructs with HA-tag, insertion of a single 
HA-tag sequence at the 5’ end of the prl-1 coding sequence was done by PCR on the pFLC1-prl-
1RB plasmid, using the primers CGACGTGCCCGACTACGCCGGATCG 
GGAATGAGCATCACCATGCGTC and 
CGGCGTAGTCGGGCACGTCGTAGGGGTAAAACAATT ACAAAAGCTGTTCTG. A start 
codon was created 6 nucleotides upstream of the beginning of the HA-tag sequence by 
mutagenesis with primers CAGAACAGCTTTTGTAATGTTTTACCCCTACGAC and 
GTCGTAGGGGTAAAACATTACAAAAGCTGTTCTG. Constructs with single point 
mutations in the prl-1 coding sequence were generated by site-directed mutagenesis on the wild-
type plasmid with following primers. GTGGCTGGTCTGGAACGAGCTCCTGTC and 
GACAGGAGCTCGTTCCAGACCAGCCAC were used for mutagenizing codon 114 to code 
for glutamic acid instead of glycine in the prl-1G114E mutant. 
GGTCTGGGACGATCTCCTGTCCTTG and CAAGGACAGGAGATCGTCCCAGACC were 
used for mutagenizing codon 116 to code for serine instead of alanine in the prl-1A116S mutant. 
For the transgene containing the prl-1 genomic region, the BAC clone CH322-158N14 in attB-
P[acman]-CmR-BW was obtained from BACPAC Resources (Children’s Hospital Oakland 
Research Institute) and directly used for Drosophila embryo injections.  
 
Fly stocks and genotypes 
Genotypes for all figure panels are listed in Table S1. Single mechanosensory neuron labelling 
with axon and synaptic markers (Syt1 or Brp) was done as described in (14). Or83c-GFP (44) 
transgenic flies were obtained from the Bloomington stock center at Indiana University (stock 
#52639). The UAS-sktl line (29) was obtained from the group of Bassem Hassan (VIB and KU 
Leuven, Belgium / ICM, Paris, France). UAS-prl-1 lines with UTRs but without tag were 
obtained from the group of Leslie Saucedo (University of Pudget Sound, USA) (45). The UAS-
InR.CFP line was obtained from the group of Hugo Stocker (ETH Zurich, Switzerland) (46). The 
PLCdPH.GFP and PLCdPH[R40L].GFP lines were obtained from the group of Patrik Verstreken 
(VIB and KU Leuven, Belgium) (32). UAS-RNAi lines were obtained either from the Vienna 
Drosophila Rescource Center (Vienna, Austria) or from the Bloomington Drosophila stock 
center (Indiana University, USA). All other fly lines were obtained from the Bloomington 
Drosophila stock center. 
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DNA injection for generation of transgenic flies was done at Rainbow Transgenic Flies, Inc. 
(Camarillo, CA, USA). All newly generated prl-1 UAS constructs were integrated site-
specifically into landing platform P{CaryP}attP2 to allow for direct comparison between the 
transgenes, without possible differences in transcription levels (47). The new transgenes appear 
to express at lower levels than the transgenes described in (45), which were randomly integrated 
via P-element transformation. First, overexpression of the newly generated transgenes with a 
strong, ubiquitous tub-gal4 (48) driver did not induce lethality as previously reported for Prl-1 
overexpression (45) and confirmed by our own experiments (data not shown). Second, 
overexpression of the new transgenes in mechanosensory neurons with pnr-gal4 did not cause 
synapse and axon phenotypes as strong as observed with the lines from (45) (data not shown). 
attB-P[acman]-CH322-158N14 (prl-1 BAC) was also integrated into P{CaryP}attP2. 
 
Generation of prl-1 alleles by CRISPR/Cas9-mediated gene editing 
Gene editing with CRISPR/Cas9 was essentially done as described in (49). The CRISPRF primer 
containing the T7 polymerase binding site and the prl-1 target site (underlined) was as follows: 
GAAATTAATACGACTCACTATAGGTTATGTCTGATGGTCGATGTTTTAGAGCTAGAA
ATAGC. This oligo was annealed to an oligo with the sequence 
AAAAGCACCGACTCGGTGCCACTTTTTCAA 
GTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC, which 
contains the rest of the synthetic guide RNA (sgRNAR, (49)), and overhangs were filled with 
KOD polymerase (Merck, catalog #71086). The double-stranded DNA template was then used as 
template for in vitro transcription with T7 RNA polymerase, using the TranscriptAid T7 High 
Yield Transcription Kit (ThermoFisher Scientific, catalog #K0441). The synthesized gRNA was 
purified by LiCl precipitation. Cas9 mRNA was produced using the plasmid pCS2-nCas9n 
(Addgene #47929, (50)). First, the plasmid was linearized by NotI digestion. Cas9 mRNA was 
then in vitro transcribed and 5’ capped using the mMESSAGE mMACHINE™ SP6 
Transcription Kit (ThermoFisher Scientific catalog #AM1340). Cas9 mRNA was purified by 
ethanol precipitation. The gRNA / Cas9 mRNA mix was prepared in water, at concentrations of 
45 ng/µl for the gRNA and 910 ng/µl for the Cas9 mRNA. The mix was injected into syncytial 
blastoderm y w embryos under halocarbon oil according to standard procedures. F0 animals were 
screened for mosaicism by PvuI digestion of a PCR product amplified from their genomic DNA 
(primer sequences CGTGTGACACTTAACAGGGAAC and CGTCAACGACTTGCTGAGG), 
spanning the target site. The PvuI recognition sequence overlaps with the predicted Cas9 cut site, 
and thus destruction of the PvuI site indicates small insertions / deletions induced by NHEJ-
mediated repair of the DNA double-strand break. Mosaic F0 animals were further crossed to a 
balancer line, and the F1 progeny was again screened in the same way to recover heterozygous 
founder flies, which were used to establish stable stocks of the different prl-1 alleles (see Figure 
S1A). 
 
Generation of anti-Prl-1 antibodies 
For full-length Drosophila Prl-1 protein production in bacteria, a PCR product of the prl-1 
coding sequence was cloned into pET28c vector with NotI / NheI, resulting in pET28c-His::prl-
1. Prl-1 expressed from this plasmid is N-terminally tagged with 6x His. pET28c-His::prl-1 was 
transformed into BL21DE3 competent cells (Agilent, catalog #200131). Prl-1 expression was 
induced in liquid LB medium cultures with an optical density between 0.6 and 0.8 by adding 
IPTG (Sigma catalog # I6758-1G) to a final concentration of 0.1 mM. Cells were grown for 
another 3-4 hrs at 25ºC, and subsequently lysed in 50 mM Tris HCl pH 7.5, 150 mM NaCl, 2 
mM DTT (lysis buffer) with sonication. His-tagged Prl-1 protein in the lysate was bound to Ni-
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NTA agarose beads (QIAGEN, catalog #30210) by gentle mixing for 2-3 hrs at 4ºC. Beads were 
pelleted by centrifugation and washed in 30mM imidazole in lysis buffer. Prl-1 protein was 
eluted with 300 mM imidazole in lysis buffer. The eluate was further purified on an Amicon 
Ultra 0.5 ml 3K UFC column (catalog #500396) according to the manufacturer protocol. Prl-1 
protein was subsequently loaded onto a denaturing polyacrylamide gel, and stained with 
Coomassie Brilliant Blue R250 (Sigma-Aldrich, catalog # 27816). Gel bands containing Prl-1 
protein were excised and used for immunization of guinea pigs. Polyclonal antibody production 
was done by Covance (Denver, PA, USA). 
 
Immunostainings 
Immunostainings on Drosophila CNS or peripheral tissue was done according to standard 
protocols. Briefly, VNCs, brains, or cuticles from the dorsal thorax were dissected from adult 
flies or pupae in 1x phosphate-buffered saline (PBS). CNS tissue and cuticles were fixed for 1.5 
hrs at room temperature (r.t.) in 2% paraformaldehyde (PFA; Merck, catalog #8.18708.1000) in 
1x PBS containing 0.1% Triton X-100 (Sigma-Aldrich, catalog #X100; PBST); body wall 
preparations of third instar wandering larvae for NMJ stainings were fixed for 25 min at r.t. in 
3.5% PFA in PBST. After several washes in PBST, tissues were blocked in 5% non-fat dry milk 
(NFDM) in PBST (“block solution”) for several hours or overnight (o.n.) at 4ºC. Incubation in 
primary antibodies was performed o.n. at 4ºC or for ≥2 hrs at r.t in block solution, followed by 
several washes in PBST, and incubation in secondary antibodies o.n. at 4ºC or for ≥2 hrs at r.t in 
block solution. After several washes in PBST, samples were mounted in SlowFadeTM Diamond 
Antifade Mountant (Invitrogen, catalog #S36972) or Vectashield (Vector Laboratories, catalog 
#H-1000). Imaging was done on an LSM710 (Zeiss, Germany) confocal light scanning 
microscope. Images were processed using ImageJ / Fiji and Adobe Photoshop. Reconstructions 
of mechanosensory neuron axons and pre-synapses were done using the “Surfaces” function in 
Imaris (Bitplane, an Oxford Instruments company). Following antibodies were used at the 
indicated concentrations. 1:10 mouse monoclonal anti-Futsch 22C10 (obtained from the 
Developmental Studies Hybridoma Bank at the University of Iowa, DSHB, (51, 52)); 1:20 rat 
monoclonal anti-NCad DN-Ex #8 (DSHB, (53)); 1:20 mouse monoclonal anti-Bruchpilot nc82 
(DSHB, (18)), 1:20 mouse monoclonal anti-FasII 1D4 (DSHB, (54)), 1:50 mouse monoclonal 
anti-Lamin ADL67.10 (DSHB, (55)), 1:500 goat polyclonal anti-Horseradish Peroxidase, 
coupled to Alexa Fluor 488 (Jackson ImmunoResearch, catalog #123-545-021), 1:500 mouse 
monoclonal anti-HA epitope 16B12 (BioLegend, catalog #901501), 1:1000 mouse monoclonal 
anti-GFP (Abcam, catalog #ab1218), 1:1000 rabbit polyclonal anti-DsRed (Clontech, catalog 
#632496), 1:200 guinea pig polyclonal anti-Prl-1 (this study). Alexa Fluor-coupled secondary 
antibodies (ThermoFisher) were used at concentrations of 1:1000 - 1:500. TRITC-Phalloidin 
(Sigma-Aldrich, catalog #P1951) was used at a concentration of 1:200 for counterstaining 
muscles in preparations of larval NMJs. For DNA staining, DAPI (ThermoFisher Scientific 
catalog #D1306) was included in the penultimate wash step of the immunostaining protocol at a 
concentration of 100 ng/ml. 
 
Dye labelling of mechanosensory neuron axons 
Dye-fills were performed as described previously (56). Briefly, adult flies were glued to an insect 
pin (Fine Science Tools, catalog #26000-25), and large mechanosensory bristles on the dorsal 
thorax were plucked manually with forceps. Flies were subsequently beheaded and their 
abdomen ripped open, and fixed o.n. at 4ºC in 3.7% paraformaldehyde in 0.2 M sodium 
carbonate-bicarbonate (“carb-bicarb”). After washes in 0.2 M carb-bicarb, flies were briefly 
dried, and the lipophilic fluorescent dyes DiD (ThermoFisher, catalog #D7757, dissolved at 20 
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mg / ml in 100% ethanol) and DiI (ThermoFisher, catalog # D3911, dissolved at 20 mg/ ml in 
1:1 dimethyl formamide : ethanol) were applied to the exposed bristle sockets with glass 
micropipettes (Sutter Instruments, catalog #BF100-50-10). Flies were incubated 48 hrs in humid 
chambers at r.t., VNCs dissected in 0.2 M carb-bicarb, and filled mechanosensory neurons 
imaged on an LSM710 (Zeiss) confocal microscope. 
 
Quantification of active zones, synaptic boutons, nuclei and filopodia 
Estimation of active zone numbers was done in Fiji / ImageJ on confocal microscopy image 
stacks of single DC neuron axons expressing Brpshort::GFP and CD8::Cherry (see Table S1 for 
full genotypes). First, a background image stack was generated by applying three filters 
(Gaussian Blur, Minimum and Maximum, each with a radius of 6 pixels). This background 
image stack was then subtracted from the original image stack. Next, an Otsu thresholding was 
performed, with 0.5 – 1% of pixels remaining, followed by image despeckling. A binary 
watershed was then applied to separate inaccurately fused objects. The 3D object counter 
function was then used with a threshold at 128 and a size filter of minimally 5 pixels to count 
segmented objects and get an estimate for active zone numbers in the anterior and the 
contralateral branch, respectively. 
Syt1 bouton numbers were estimated by reconstruction of surfaces in Imaris (Bitplane, an 
Oxford Instruments company). A region of interest was defined on the contralateral collateral 
corresponding to the region in which terminal arbor territories were quantified for other figures 
(see Fig. S2). Boutons were then segmented using the “Surfaces” function of Imaris, allowing 
touching objects to be split (seed points diameter 0.4 µm). 
Nuclei counting in Fiji / ImageJ was done in confocal microscopy image stacks of VNCs stained 
with DAPI for DNA and Lamin to visualize the nuclear envelope, in regions of interest in the 
VNC (anterior and posterior, respectively). First, contrast of both channels was optimized across 
the whole image stack with the “Enhance Contrast” function, so that 1% of pixels were saturated. 
Next, the Lamin channel was subtracted from the DAPI channel in the whole stack, to better 
separate the DAPI signal from individual nuclei, and avoid overlap where nuclei are very close 
to each other. Subsequently, an Otsu thresholding was performed, with 4% of pixels remaining 
in superficial sections and 15% remaining in sections deeper in the tissue, respectively. A binary 
watershed was then applied to separate inaccurately fused objects. Finally, segmented objects 
were counted with the 3D object counter function, using a threshold at 128 and a size filter of 
minimally 20 pixels. 
Filopodia were counted manually in Fiji / ImageJ in confocal microscopy image stacks of 
developing prl-1 null and control animals with single mechanosensory neurons labelled with 
CD8::GFP and Cherry::Syt1. A length threshold of 1.5 µm was set for considering a membrane 
protrusion as a filopodium. 
 
Correlative light and electron microscopy 
Correlative light and electron microscopy (CLEM) was done essentially as described in (14), 
except that the EM part was performed with a serial Block-Face Scanning electron microscope 
(SBF-SEM) and a transmission electron microscopy (TEM), and not block-face scanning 
electron microscopy with focused ion beam based milling (FIB-SEM). Fly thoraces were first 
fixed in 0.5% glutaraldehyde (Electron Microscopy Sciences, catalog #16019) and 2% 
paraformaldehyde (Electron Microscopy Sciences, catalog #157-8) in 0.15 M sodium cacodylate 
buffer. Single labelled mechanosensory neurons in prl-1 null and control VNCs (see Table S1 for 
full genotypes) were marked by near-infrared branding (NIRB, (57)) with a MaiTai DeepSee 
two-photon laser on an LSM710 (Zeiss) confocal microscope as described in (14). After post-
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fixation in 2% glutaraldehyde in cacodylate buffer, samples were processed for TEM as follows. 
Samples were rinsed in 0,1M sodium cacodylate buffer then osmicated in 1% osmium tetroxide 
(Electron Microscopy Sciences, catalog #RT19151) with 1,5% potassium ferrocyanide (Sigma 
Aldrich, catalog #P3289) in 0,1M sodium cacodylate buffer. Next, samples were stained with 
0,2% tannic acid (Electron Microscopy Sciences, catalog #RT 21710) for 30 minutes and 
followed by 0,5% uranyl acetate (SPI-chem, catalog #02624-AB) in 25% methanol overnight. 
The next day, samples were stained en bloc with lead aspartate and dehydrated with graded 
series of ethanol followed by flat embedding in Agar 100 (Laborimpex). Then flat-embedded 
samples were mounted on aluminum pin stubs (Gatan, catalog #10-006002-50)) with conductive 
epoxy (Circuit Works, catalog #16043)). To approach the region of interest based on the 
branding marks, a Zeiss Sigma Variable pressure SBF-SEM with 3View technology (Gatan) was 
used. Imaging was done at 1,3 kV with a pixel size of 20 nm and sections of 200 nm thickness. 
After locating the region of interest, serial ultrathin sections of 70nm were cut using a Reichert 
Ultracut E ultramicrotome. All sections were collected on triple slot grids (Ted Pella, catalog 
#1816) and imaged with a JEOL JEM-1400-LaB6 Transmission Electron Microscope with a 
Olympus Quemesa 11Mpx camera at 80kV. 
 
Western blotting 
Polyacrylamide gels for separation of proteins, and western blotting to nitrocellulose membranes 
was done according to standard procedures. For the western blot shown in Fig. S1C, extracts 
were prepared from adult fly heads, and the equivalent of 5 heads was loaded per lane. The 
membrane was cut horizontally between the molecular weight marker bands corresponding to 25 
and 50 kiloDaltons, respectively, and incubated in following primary antibodies: 1:1000 guinea 
pig polyclonal anti-Prl-1 (this study), 1:5000 mouse monoclonal anti-beta Tubulin E7 (DSHB, 
(58)). HRP-conjugated secondary antibodies against guinea pig and mouse, respectively (Jackson 
ImmunoResearch, catalog #106-035-003 and #115-035-003) were used at a concentration of 
1:5000. Chemiluminescence was generated with PierceTM ECL Western Blotting substrate 
(ThermoFisher Scientific, catalog #32209) and detected on a ChemiDoc-It 500 Imaging system 
(UVP). 
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Figure S1. prl-1 null mutants generated by CRISPR/Cas9-mediated gene editing. (A) Gene 
structure of the Drosophila prl-1 RA isoform, according to flybase.org. Exons are depicted with 
boxes, introns with connecting lines. Open reading frame (ORF) is colored in orange. In the 
zoom-in on the sequence, amino acids are indicated above the coding sequence, from F at 
position 24 of the Prl-1 protein to N at position 36. “ts” denotes the target site for DNA cleavage 
by Cas9, directed to this site by the guide RNA used. The small insertions / deletions for the prl-
1 alleles 1-7 are indicated below. To the right of the sequence, amino acid positions are 
indicated, at which a premature termination codon is introduced through frame-shifts in alleles 1-
5 and 7. “kb”, kilobase. (B) Domain organization of the Prl-1 protein. Green boxes indicate 
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regions required for phosphatase activity, yellow boxes indicate sequences important for 
membrane localization (16). The target site for the guide RNA / Cas9-mediated DNA cleavage is 
indicated as in A. I33 and N36 correspond to the amino acids highlighted in A. “aa”, amino acid. 
(C) Detection of Prl-1 protein in head extracts from adult flies of the indicated genotypes. 
Tubulin was used as a loading control. (D) Quantification of adult fly hatching at different time 
periods (d, days) after egg laying. “rescued” denotes genotypes with one copy of the prl-1 gene 
inserted into the genome as a bacterial artificial chromosome transgene. Note that for control 
genotypes, around 80% of all adults hatch 10-12 days after egg laying, while only around 30% of 
prl-1 null flies hatch already at that time, and around 40% hatch only after 13-15 days. (E, F) 
External morphology and size of prl-1 mutant animals are normal. Error bars in F represent 
standard deviation. 
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Figure S2. Quantification of contralateral branch arbor territory. Procedure followed to measure 
the branch arbor territory is exemplified for a control (top) and a DC neuron overexpressing 
constitutively active (CA) Akt (bottom), which forms exuberant arbors. As a first landmark, 
location of the CNS midline is determined with the help of the NCadherin neuropil staining 
(blue, note that the midline is located in the middle between prothoracic neuromeres and terminal 
projections of wing margin sensory neurons, outlined in orange in the top left panel). Location of 
the first and the second main branch points of DC neurons is determined with the axon staining 
(red). The distance between the second branch point and the midline (d1) is considered as half 
the length of the contralateral projection. The region for quantification of synaptic arborizations 
is defined as the central third (d3) of the contralateral projection. In this region, the area (A) 
filled by the axonal arborizations (CD8.GFP axon label channel) in a maximum projection of the 
3D image stack is traced automatically in Adobe Photoshop. This area is then normalized to the 
distance between the first branch point and the midline to correct for variability in VNC size / 
flattening during mounting of the samples. 
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Figure S3. DC neuron cell body size and morphology, and axon caliber, are normal in prl-1 null 
animals. (A) Immunostaining of DC neurons underneath the dorsal thorax cuticle, with an 
antibody against the microtubule-associated protein Futsch. Arrowheads point to the large DC 
bristles. “cb”, cell body; “d”, dendrite; “a”, axon. Two additional examples for each genotype are 
indicated in the magnification panels. Scale bars: top panels, 20 µm; bottom panels, 5 µm. (B) 
Quantification of cell body circumference for 5 control and 5 prl-1 null DC neurons, relative to 
the average of the controls. Error bars represent standard deviation. (C) Same samples as in Fig. 
1D-F, with magnifications on an axon segment (stained for CD8.GFP) at the site of entry into the 
CNS. No differences in axon caliber are observed. Scale bars: left panels, 20 µm; right panels, 
2.5 µm. 
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Figure S4. CNS axon projections of SC neurons are normal in prl-1 null animals. Posterior 
scutellar (pSC) mechanosensory neurons were labelled with a lipophilic fluorescent dye in prl-1 
heterozygous and homozygous null animals. Except for slightly shorter posterior projections due 
to reduced VNC size, no defects were observed in prl-1 null flies. Scale bar: 50 µm. 
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Figure S5. Estimation of presynaptic active zone numbers in anterior and contralateral branches, 
respectively. (A) Examples of the anterior projection of a DC neuron in a prl-1 heterozygous and 
a homozygous null animal, respectively. Pre-synaptic active zones are stained with the marker 
Bruchpilot (Brp)short.GFP (green), the axon is labelled with CD8.Cherry (red). Insets show a 
magnification on active zones of the distal branch segment. No differences are observed in 
appearance and distribution of active zones in the anterior branch. Asterisks indicate projections 
of another neuron (mechanosensory neuron innervating a small bristle on the central dorsal 
thorax). (B) Axon and pre-synaptic active zone labelling in the contralateral axon collateral (top 
and middle panels). Bottom panels show the result of segmentation of active zones using the 3D 
object counter plugin in Fiji / ImageJ (see Experimental Procedures). The counts of the 
segmented objects was used as the estimate of active zone numbers plotted in Fig. 1O,P. Active 
zone number is strongly reduced in the contralateral axon collateral in prl-1 null animals. Scale 
bars: 10 µm. 
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Figure S6. Ultrastructure of DC neuron active zones appears normal in prl-1 null animals. Left 
and middle panels, overview transmission electron microscopy (TEM) images of cross-sections 
of the DC neuron axon contralateral branch. Individual DC neuron axons were labelled with the 
fluorescent marker CD8.Cherry and imaged with a confocal light microscope (not shown). At the 
same time, branding marks were introduced into the tissue by near-infrared branding (NIRB; (14, 
57)). The marks are recognizable after tissue processing for TEM and allow for identification 
and ultrastructural imaging of the DC neuron. Right panels show magnification of individual pre-
synaptic active zones, with dense projections of characteristic shape (“T bars”) and close-by 
synaptic vesicles. No striking differences are observed in the ultrastructure of synaptic 
components upon loss of prl-1 (bottom panels). m, mitochondria. Scale bars: left panels, 500 nm; 
right panels, 125 nm. 
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Figure S7. prl-1 is broadly required for CNS development and function. (A) Example of a 
locomotor test setup with in each tube 7 female flies aged 7-10 days. Compared to prl-1 
hemizygous mutant flies rescued by a BAC transgene (left), non-rescued prl-1 mutants tend to 
stay in the lower part of the test tube and have difficulties flying / climbing up the tube walls 
(right). See Movie S1. (B) Flies were tapped down every 30 sec and presence in the upper half of 
the test tube was quantified for each cycle. (C) Quantification of flight events in the same test 
setup. (D-G) GFP expressed in one class of odorant receptor neurons (ORNs) from an or83c-gfp 
transgene reveals defects in ORN targeting, but not cell numbers. D, F, visualization of ORN cell 
bodies in the antenna of control and prl-1 null flies. E, control ORNs target to one specific 
glomerulus in the antennal lobe, and the target area appears homogenous in a maximum 
projection of a confocal microscopy image stack. G, ORN target area appears disrupted / less 
homogenous in prl-1 mutants. (H) Numbers of ORN neurons (expressing or83c) are not reduced 
in prl-1 null flies (P value 0.16 in a Mann-Whitney test). (I) Quantification of the target area of 
or83c ORNs in maximum intensity projections of control and prl-1 null antennal lobes reveals a 
size reduction in the mutants (***, p<0.001, Mann-Whitney test). Scale bars: D, 50 µm; E, 20 
µm.  
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Figure S8. Neuromuscular junction (NMJ) morphology appears normal in prl-1 null animals. 
NMJs of third-instar larvae were stained for the active zone component Bruchpilot (Brp, 
antibody nc82), anti-horseradish peroxidase (HRP), which labels the axon membrane, and F-
actin (strongly visible in the post-synaptic muscle). Images show an example of an NMJ on 
muscle 4 in abdominal segment 4, each for wild-type and prl-1 null animals. No gross 
morphology defects are observed upon loss of prl-1. Scale bar: 10 µm. 
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Figure S9. Mushroom body defects in prl-1 null animals. (A) Brain of a control animal stained 
for Fasciclin II (FasII) and NCad. FasII staining prominently labels mushroom body axon 
projections. The mushroom body lobes that project centrally do not cross the midline (arrowhead 
in magnification panel). Scale bar: 20 µm. (B) Two examples of mushroom body axon defects in 
prl-1 null animals, with midline crossing of some (B) or all (B’) axons. (C) Example of a prl-1 
null animal rescued with a BAC transgene. (D) Quantification of mushroom body defects as 
exemplified in A-C. ***, p<0.0001, Chi-square test. 
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Figure S10. VNC neuropil size, but not cell numbers, is reduced upon loss of prl-1. (A) Adult 
flies (top) and their central nervous systems (brain and VNC; bottom) of the indicated genotypes. 
The prl-1 null fly (middle) is of normal size, but particularly the VNC is smaller than in the 
heterozygous or the BAC-transgene rescued prl-1 null fly. Cartoon on the right shows the 
outlines of the prl-1 null VNC (red) and of the rescued VNC (blue) on top of the heterozygous 
VNC (green). (B) Side-to-side comparison of one half of a wild-type and of a prl-1 null CNS, 
respectively. Note reduction in size of both brain and VNC neuropiles. (C) Quantification of the 
VNC area relative to controls, in maximum projections of confocal image stacks of VNCs 
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stained for NCad as in panel B. **, p<0.005, Mann-Whitney test. (D) Labelling of nuclear 
envelopes with anti-Lamin staining (green), DNA with DAPI stain (blue) and the neuropile with 
anti-NCad (red) allows estimation of cell numbers in different areas of the VNC. Examples show 
anterior and posterior VNC parts, respectively, of a heterozygous and of a homozygous prl-1 null 
fly. Note that because the VNC size is reduced, nuclei appear more densely packed in the 
homozygous mutant (middle bottom panel). (E) Nuclei numbers were estimated with the 3D 
object counter plugin in Fiji / ImageJ (see Experimental Procedures). Despite a potential 
underestimation of nuclei numbers in the homozygous mutant samples due to dense packing, 
there are no significant differences between the genotypes (n.s.; unpaired t tests). Scale bars: A 
top, 1 mm; A bottom, 200 µm; B, 100 µm; D left and right, 50 µm; D center, 20 µm. 
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Figure S11. Quantification of synaptic boutons based on Synaptotagmin1 (Syt1).Cherry marker 
expression. Top panels, example of a single mechanosensory neuron expressing CD8 axonal and 
Syt1 presynaptic markers, and magnification of the contralateral collateral. Middle panels, using 
Imaris software (Bitplane), boutons of Syt1 were reconstructed for the central part of the 
contralateral mechanosensory collateral, in the same region as terminal arbor complexity was 
quantified in Fig. 3D. Numbers of Syt1 boutons (“objects”) are plotted in the bottom panel for 
the same genotypes as shown in Fig. 3D. n.s., non significant; *, p<0.05; ***, p<0.001, ordinary 
one-way Anova with multiple comparisons. 
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Figure S12. Full DC neuron projection patterns upon manipulation of the InR / Akt signaling 
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pathway. Genotypes correspond to the ones in Fig. 3. Note strong phenotypes in arborizations of 
the contralateral axon collateral, while the anterior and posterior branches, respectively, are all 
similar within a certain normal variability. Scale bar: 20 µm. 
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Figure S13. DC neuron projections are normal upon pdk1 knockdown. Examples of pdk1 
knockdown in mechanosensory neurons, with two different RNAi lines (indicated in brackets), 
are shown. Projections appear normal, without changes in arborizations in the contralateral or 
other branches. Scale bar: 20 µm.  
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Figure S14. DC neuron projections appear normal upon knockdown of several suggested 
downstream Prl-1 protein targets. Two examples are shown for knockdown of each gene. No 
phenotype was observed in any of them. Scale bar: 20 µm. 
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Figure S15. Amino acid alignment of Drosophila (D.m.) Prl-1 and human (H.s.) Prl-3 and 
PTEN proteins. Identical amino acids for all three proteins are indicated with asterisks, identities 
/ similarities between some of the proteins with dots. The conserved glycine at position 114 of 
Prl-1 (green), and the alanine at position 116 of Prl-1 (blue) have been suggested to be essential 
for lipid phosphatase activity, but not for protein phosphatase activity, of human PTEN and Prl-
3, respectively (24, 31).   
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Figure S16. Full mechanosensory neuron projection patterns and Syt1 bouton quantification in 
prl-1 null animals that express prl-1 variants in mechanosensory neurons. Examples of the full 
DC neuron projection pattern are shown for each genotype. A magnification of the contralateral 
branch is also shown for one animal of each genotype. The whole VNC is shown in bottom 
panels, highlighting that in prl-1 null flies, the DC neurons project into a smaller VNC. Only the 
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wild-type (wt) prl-1 transgene expressed in mechanosensory neurons can rescue synaptic 
arborizations in the contralateral axon collateral. See text for details. Right panels, quantification 
of Syt1 boutons as in Fig. S11. Note that for the prl-1 -/- genotype, the data from Fig. S11 is 
replotted. **, p<0.01; Mann-Whitney test. Scale bars: whole DC neuron projection panels, 20 
µm; whole VNC panels, 50 µm; magnifications panels, 10 µm. 
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Figure S17. Localization of wild-type PLCdPH.GFP in a control and in an animal with 
knockdown of prl-1 expression in mechanosensory neurons, at approximately 50% pupal 
development. CD8.Cherry axonal marker and PLCdPH.GFP, and in the bottom panels the RNAi 
construct targeting prl-1, were expressed in mechanosensory neurons innervating bristles of the 
central thorax with the pnr-gal4 driver (see Fig. 6A). Ventral nerve cords were imaged without 
fixation. Scale bar, 20 µm. 
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Figure S18. Filopodia, satellite growth cones and stabilized arborizations in developing DC 
neurons. (A) Examples of Cherry.Synaptotagmin1-containing satellite growth cones 
(arrowheads) in control and prl-1 null animals at mid-stages of contralateral axon collateral 
development. (B) Morphology of stabilized contralateral axon collaterals at late stages of DC 
neuron development. Scale bar: 2.5 µm. 
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Figure S19. Predicted RNA binding proteins (RBP) binding motifs in the UTRs of the prl-1 
mRNA (isoform RB; flybase.org). The specific RBP is indicated in blue on the top left of each 
diagram of the prl-1 mRNA. Consensus sequences for binding by the RBP are indicated by blue 
bars in the diagrams. The three members of the Elav family of RBPs are grouped into one 
diagram. Names of mammalian homologues of the RBPs are also indicated. The sequence 
consensus that was used for identifying motifs is indicated below each diagram. Where there is 
ambiguity for which nucleotide can be found at a particular position, following abbreviations are 
used: b, G or C or T; d, A or G or T; h, A or C or T; k, G or T; m, A or C; w, A or T; v, A or G or 
C; r, A or G; s, G or C. A non-optimal consensus sequence is shown for Fmr, with a G instead of 
an A at position 5. Motifs were searched for by a combination of the search tool RBPmap 
(http://rbpmap.technion.ac.il) and manual searching based on the consensus sequences provided 
in (59, 60). CDS, coding sequence; nt, nucleotides. 
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Figure S20. Tagged Prl-1 is enriched in the contralateral axon collateral of mechanosensory 
neurons during development. HA.Prl-1 was expressed from transgenes with and without UTRs, 
respectively, in all mechanosensory neurons innervating bristles in the central dorsal thorax (see 
Fig. 6A). Staining for the HA epitope was done in pupal VNCs at approximately 50% pupal 
development; note higher gain for imaging of HA.Prl-1 expressed from a transgene without 
UTRs (right). Particularly HA.Prl-1 expressed from the transgene without UTRs, which likely 
reflects distribution of endogenously expressed Prl-1 (see main text), is enriched in contralateral 
axon collaterals (arrowheads). Scale bar: 50 µm. 
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Figure S21. Localization of the general axon marker CD8.Cherry in mechanosensory neurons 
innervating bristles of the central thorax (see Fig. 6A). (A) CD8.Cherry is not enriched 
specifically in any axon collaterals, and reduction of contralateral collateral arbor complexity in 
prl-1 null mutant animals (right panels) does not reduce CD8.Cherry signal significantly in these 
collaterals (see high magnification panel, analogous to high magnification panels in Fig. 6B). (B) 
Quantification of CD8.Cherry signal ratio between contralateral collaterals and anterior 
collaterals (analogous to Fig. 6C,D). Intensity density in regions of interest as shown in high 
magnification panels in A) was measured in Fiji software. Scale bars, 20 µm for low 
magnification panels, 10 µm for high magnification panels. 
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Figure S22. Localization of InR.CFP in mechanosensory neurons innervating bristles of the 
central thorax. InR.CFP was expressed using the pnr-gal4 driver (see Fig. 6A), and its 
localization was assessed by immunostaining with an anti-GFP antibody at approximately 40% 
and 70% pupal development, respectively. Note unspecific expression of the InR.CFP construct 
in processes of other cells at the earlier stage (arrowheads). High magnification panels show the 
contralateral collateral projections. At 40% pupal development, InR.CFP is localized in the 
contralateral axon collateral of mechanosensory neurons (arrows). At later stages, InR.CFP 
appears distributed at similar levels across all collaterals (bottom panels). Scale bars, 20 µm for 
low magnification panels, 10 µm for high magnification panels. 
 
 
Movie S1. Locomotor test with in each tube 7 female flies aged 7-10 days, see Fig. S7. Tube on 
the left contains prl-1 null flies rescued with a prl-1 BAC transgene, tube on the right contains 
prl-1 null flies. Note that prl-1 null flies do not fly, walk more slowly than rescued flies, 
frequently stay in the bottom of the tube, and have difficulties getting back to their legs when on 
the back. Note also the occasional held-up wing phenotype. 
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Table S1. List of all genotypes for all figure panels 
 
Figure panel Full genotype References 
1A-C 
w[*]; 
+; 
+ 
 
1D 
y[*] w[*] / w[*]; 
P{w[+mC] DC1.4-Flp} / +; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 /+ 
(14) 
(61) 
1E, I 
y[*] w[*]; 
P{w[+mC] DC1.4-Flp} / P{KK108293}VIE-260B; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / + 
(15) 
1F, J 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 /+ 
 
1G, K 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P[acman]{w[+mC] prl-1}attP2 
 
1O, P prl-1 -/+ 
w[*] P{w[+mC] tub-FRT>Gal80>FRT} / w[*]; 
prl-1[2 or 6] / CyO; 
P{w[+mC] DC1.4-Flp} P{GawB}pnrMD237 / P{UAS-Brpshort::GFP} P{UAS-CD8::Cherry} 
 
1O, P prl-1 -/- 
w[*] P{w[+mC] tub-FRT>Gal80>FRT} / w[*]; 
prl-1[2] / prl-1[6]; 
P{w[+mC] DC1.4-Flp} P{GawB}pnrMD237 / P{UAS-Brpshort::GFP} P{UAS-CD8::Cherry} 
 
1Q 
w[*] P{w[+mC] tub-FRT>Gal80>FRT} / Y; 
P{w[+mC] DC1.4-Flp} P{UAS-Brpshort::GFP} / +; 
P{GawB}pnrMD237 P{UAS-CD8::Cherry} / p{w[+mC] UAS-HA.prl-1noUTRs}attP2 
(62) 
(42) 
F. Schnorrer, 
personal comm. to 
Flybase 
   
2A, C, E 
w[*]; 
+ / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / + 
 
2B, D, F 
w[*]; 
P{w[+mC] UAS-Prl-1} / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / + 
(45) 
   
3 control 
w[*] / y w[*]; 
+ / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / + 
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3 Akt RNAi 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.HM04007}attP2 
(63) 
3 PTEN RNAi 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.HMS00044}attP2 
 
3 Akt CA 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{w[+mC]=UAS-myr-Akt1.V}3 
(20) 
3 InR RNAi 
w[*] / y[1] v[1]; 
P{y[+t7.7] v[+t1.8]=TRiP.HMS03166}attP40 / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / + 
 
3 InR dominant 
negative 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{w[+mC]=UAS-InR.K1409A}3 
A. Parks, personal 
comm. to Flybase 
3 Chico RNAi 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.HMS01553}attP2 
 
3 Pi3K RNAi 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.JF02770}attP2 
 
3 Raptor RNAi 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.HMS00124}attP2 
 
3 Prl-1 +/- PTEN 
RNAi 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp} prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.HMS00044}attP2 
 
3 Prl-1 -/- 
w[*]; 
prl-1[2] / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 / P{GawB}pnrMD237 P{w[+mC] DC1.4-Flp}; 
 
3 Prl-1 -/- Akt CA 
w[*] / y[1] v[1]; 
prl-1[2] / P{w[+mC] DC1.4-Flp} prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{w[+mC]=UAS-myr-Akt1.V}3 
 
3 Akt RNAi + 
CD8 OE 
w[*] / y[1] v[1]; 
+ / P{UAS-CD8::Cherry}; 
P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.HM04007}attP2 
 
3 Akt RNAi + 
Prl-1 OE 
w[*] / y[1] v[1]; 
+ / P{w[+mC] UAS-Prl-1}; 
P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.HM04007}attP2 
(45) 
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4A, C control 
w[*]; 
P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / TM6B Tb 
 
4A prl-1 -/- 
w[*]; 
prl-1[4] / prl-1[4]; 
+ 
 
4A, C Sktl OE 
w[*] / P{w[+mC]=UAS-sktl.H}1, w[*]; 
+ / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / + 
(29) 
4A Sktl OE + GFP 
OE 
w[*] / P{w[+mC]=UAS-sktl.H}1, w[*]; 
P{w[+mC] DC1.4-Flp} P{UAS-Brpshort::GFP} / +; 
P{GawB}pnrMD237 P{UAS-CD8::Cherry} / + 
 
4A, C Sktl OE + 
Prl-1 OE 
w[*] / P{w[+mC]=UAS-sktl.H}1, w[*]; 
P{w[+mC] UAS-Prl-1} / +; 
P{GawB}pnrMD237 P{UAS-CD8::Cherry} / + 
(45) 
4B control 
w[*] / y w; 
+ / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / + 
 
4B Sktl OE 
w[*] / P{w[+mC]=UAS-sktl.H}1, w[*]; 
+ / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / + 
 
4D,E prl-1 -/+ 
control 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / CyO; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / TM2 
 
4D,E prl-1 -/- + 
prl-1 [G114E] 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / p{w[+mC] UAS-HA.prl-1[G114E]withUTRs}attP2 
 
4D, E prl-1 -/- + wt 
prl-1 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / p{w[+mC] UAS-HA.prl-1[wt]withUTRs}attP2 
 
4F, G control 
w[*]; 
prl-1[2] /CyO; 
P{GawB}pnrMD237 P{UAS-CD8::Cherry} / TM6 
 
4F, G prl-1 -/- 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[6]; 
P{GawB}pnrMD237 P{UAS-CD8::Cherry} / TM6 
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4F, G prl-1 -/- 
PLCdPH.GFP 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[6]; 
P{GawB}pnrMD237 P{UAS-CD8::Cherry} / P{w+UAS-PLCd-PH-EGFP} 
(32) 
4F, G prl-1 -/- 
PLCdPH[R40L].GFP 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[6]; 
P{GawB}pnrMD237 P{UAS-CD8::Cherry} / P{w+UAS-PLCd-PH[R40L]-EGFP} 
 
4H control 
w[*] P{w[+mC] tub-FRT>Gal80>FRT} / w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / CyO; 
P{GawB}pnrMD237 P{UAS-CD8::Cherry} / P{w+UAS-PLCd-PH-EGFP} 
 
4H prl-1 -/- 
w[*] P{w[+mC] tub-FRT>Gal80>FRT} / w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[6]; 
P{GawB}pnrMD237 P{UAS-CD8::Cherry} / TM2 
 
4H prl-1 -/- 
PLCdPH.GFP 
w[*] P{w[+mC] tub-FRT>Gal80>FRT} / w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[6]; 
P{GawB}pnrMD237 P{UAS-CD8::Cherry} / P{w+UAS-PLCd-PH-EGFP} 
 
4H prl-1 -/- 
PLCdPH[R40L].GFP 
w[*] P{w[+mC] tub-FRT>Gal80>FRT} / w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[6]; 
P{GawB}pnrMD237 P{UAS-CD8::Cherry} / P{w+UAS-PLCd-PH[R40L]-EGFP} 
 
   
5 control 
Either prl-1 heterozygous mutant or +/+ animals were used as controls, with same results: 
w[*]; 
+ / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 / P{w[+mC] DC1.4-Flp} P{GawB}pnrMD237 
or 
y[*] w[*] / w[*]; 
P{w[+mC] DC1.4-Flp} / +; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / + 
 
5 prl-1 -/- 
w[*]; 
prl-1[2] / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 / P{w[+mC] DC1.4-Flp} P{GawB}pnrMD237 
 
   
6B prl-1 -/+; pnr> 
HA.prl-1 with 
UTRs 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / CyO; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / p{w[+mC] UAS-HA.prl-1[wt]withUTRs}attP2 
 
6B prl-1 -/-; pnr> 
HA.prl-1 with 
UTRs 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / p{w[+mC] UAS-HA.prl-1[wt]withUTRs}attP2 
 
6B prl-1 -/+; pnr> 
HA.prl-1 without 
UTRs 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / CyO; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / p{w[+mC] UAS-HA.prl-1[wt]noUTRs}attP2 
 
 38 
6B prl-1 -/-; pnr> 
HA.prl-1 without 
UTRs 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / p{w[+mC] UAS-HA.prl-1[wt]noUTRs}attP2 
 
6F controls 
w[*]; 
P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / TM6B Tb 
 
6F wt rescue 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / p{w[+mC] UAS-HA.prl-1[wt]withUTRs}attP2 
 
6F rescue 
no UTRs 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / p{w[+mC] UAS-HA.prl-1[wt]noUTRs}attP2 
 
   
S1 C 
prl-1 +/+: y[*] w[*] 
prl-1 -/+: prl-1[2] / CyO 
prl-1 -/-: prl-1[2] / prl-1[2] 
 
S1 D prl-1 -/- 
w[*] / +; 
prl-1[2] / Df(2L)r10; 
TM2 / + 
 
S1 D prl-1 -/- 
rescued 
w[*] / +; 
prl-1[2] / Df(2L)r10; 
P[acman]{w[+mC] prl-1}attP2 / + 
 
S1 D prl-1 -/+ 
w[*] / +; 
prl-1[2] or Df(2L)r10 / CyO; 
TM2 / + 
 
S1 D prl-1 -/+ 
“rescued” 
w[*] / +; 
prl-1[2] or Df(2L)r10 / CyO; 
P[acman]{w[+mC] prl-1}attP2 / + 
 
S1 E prl-1 -/+ 
w[*]; 
Bl / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 / P{w[+mC] DC1.4-Flp} P{GawB}pnrMD237 
 
S1 E prl-1 -/- 
w[*]; 
prl-1[2] / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 / P{w[+mC] DC1.4-Flp} P{GawB}pnrMD237 
 
   
S2 control 
y[*] w[*] / w[*]; 
P{w[+mC] DC1.4-Flp} / +; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 /+ 
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S2 Akt CA 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{w[+mC]=UAS-myr-Akt1.V}3 
 
   
S3A,B control 
w[*] / +; 
prl-1[2] / Df(2L)r10; 
P[acman]{w[+mC] prl-1}attP2 / + 
 
S3A, B prl-1 -/- 
w[*] / +; 
prl-1[2] / Df(2L)r10; 
TM2 / + 
 
S3C control 
y[*] w[*] / w[*]; 
P{w[+mC] DC1.4-Flp} / +; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 /+ 
 
S3C prl-1 RNAi 
y[*] w[*]; 
P{w[+mC] DC1.4-Flp} / P{KK108293}VIE-260B; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / + 
 
S3C prl-1 -/- 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 /+ 
 
   
S4 prl-1 -/+ 
w[*] / +; 
prl-1[2] or Df(2L)r10 / CyO; 
+ 
 
S4 prl-1 -/- 
w[*] / +; 
prl-1[2] / Df(2L)r10; 
+ 
 
   
S5 prl-1 +/- 
w[*] P{w[+mC] tub-FRT>Gal80>FRT} / w[*]; 
prl-1[2 or 6] / CyO; 
P{w[+mC] DC1.4-Flp} P{GawB}pnrMD237 / P{UAS-Brpshort::GFP} P{UAS-CD8::Cherry} 
 
S5 prl-1 -/- 
w[*] P{w[+mC] tub-FRT>Gal80>FRT} / w[*]; 
prl-1[2] / prl-1[6]; 
P{w[+mC] DC1.4-Flp} P{GawB}pnrMD237 / P{UAS-Brpshort::GFP} P{UAS-CD8::Cherry} 
 
   
S6 prl-1 -/+ 
w[*] P{w[+mC] tub-FRT>Gal80>FRT} / w[*]; 
prl-1[2] or prl-1[4] / CyO; 
P{w[+mC] DC1.4-Flp} P{GawB}pnrMD237 / P{UAS-Brpshort::GFP} P{UAS-CD8::Cherry} 
 
S6 prl-1 -/- 
w[*] P{w[+mC] tub-FRT>Gal80>FRT} / w[*]; 
prl-1[2] / prl-1[4]; 
P{w[+mC] DC1.4-Flp} P{GawB}pnrMD237 / P{UAS-Brpshort::GFP} P{UAS-CD8::Cherry} 
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S7A-C rescue 
w[*]; 
prl-1[2] / Df(2L)r10; 
+ / P[acman]{w[+mC] prl-1}attP2 
 
S7A-C mutant 
w[*]; 
prl-1[2] / Df(2L)r10; 
+ / TM2 
 
S7D-I, control 
w[*]; 
prl-1[2] / CyO; 
Or83c-CD8::GFP / TM2 
 
 
(44) 
S7D-I, prl-1 -/- 
w[*]; 
prl-1[2] / prl-1[2]; 
Or83c-CD8::GFP / TM2 
 
   
S8 prl-1 +/+ 
+; 
+; 
+ (CantonS) 
 
S8 prl-1 -/- 
w; 
prl-1[2] / prl-1[2]; 
+ 
 
   
S9A 
w[*]; 
prl-1[2] / CyO; 
Or83c-CD8::GFP / TM2 
 
S9B 
w[*]; 
prl-1[2] / prl-1[2]; 
Or83c-CD8::GFP / TM2 
 
S9C 
w[*]; 
prl-1[2] / prl-1[2]; 
Or83c-CD8::GFP / P[acman]{w[+mC] prl-1}attP2 
 
   
S10A prl-1 -/+ 
w[*] / +; 
prl-1[2] or Df(2L)r10 / CyO; 
+ / TM2 
 
S10A prl-1 -/- 
w[*] / +; 
prl-1[2] / Df(2L)r10; 
+ / TM2 
 
S10A prl-1 -/- 
rescued 
w[*] / +; 
prl-1[2] / Df(2L)r10; 
+ / P[acman]{w[+mC] prl-1}attP2 
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S10B, C prl-1 +/+ 
y[*] w[*]; 
+; 
+ 
 
S10B, C prl-1 -/- 
w[*]; 
prl-1[4] / prl-1[4]; 
+ 
 
S10D, E prl-1 -/+ 
w[*]; 
prl-1[4] or prl-1[2] / CyO; 
+ 
 
S10D, E prl-1 -/- 
w[*]; 
prl-1[4] / prl-1[2]; 
+ 
 
   
S11 example 
(same as in Fig. 
3A) 
w[*] / y w[*]; 
+ / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / + 
 
   
S12 control 
y[*] w[*] / w[*]; 
P{w[+mC] DC1.4-Flp} / +; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 /+ 
 
S12 prl-1 -/+ 
w[*]; 
+ / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 / P{w[+mC] DC1.4-Flp} P{GawB}pnrMD237 
 
S12 prl-1 -/- 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 /+ 
 
S12 prl-1 -/- 
PBAC[prl-1] 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P[acman]{w[+mC] prl-1}attP2 
 
S12 prl-1 -/- pnr > 
Prl-1 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[4]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{w[+mC] UAS-Prl-1} 
(45) 
S12 InR RNAi 
w[*] / y[1] v[1]; 
P{y[+t7.7] v[+t1.8]=TRiP.HMS03166}attP40 / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / + 
 
S12 InR DN 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{w[+mC]=UAS-InR.K1409A}3 
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S12 chico RNAi 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.HMS01553}attP2 
 
S12 p110 RNAi 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.JF02770}attP2 
 
S12 raptor RNAi 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp}; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.HMS00124}attP2 
 
S12 prl-1 -/+ 
PTEN RNAi 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp} prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.HMS00044}attP2 
 
S12 prl-1 -/- 
AktCA 
w[*] / y[1] v[1]; 
prl-1[2] / P{w[+mC] DC1.4-Flp} prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{w[+mC]=UAS-myr-Akt1.V}3 
 
   
S13 control 
y[*] w[*] / w[*]; 
P{w[+mC] DC1.4-Flp} / +; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 /+ 
 
S13 Pdk1 RNAi 
(TRiP.HMS01250) 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp} prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.HMS01250}attP2 
 
S13 Pdk1 RNAi 
(TRiP.GL00489) 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp} prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.GL00489}attP2 
 
 
   
S14 controls 
y[*] w[*] / w[*]; 
P{w[+mC] DC1.4-Flp} / +; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 /+ 
 
S14 rolled / MAPK 
RNAi 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp} prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.HMS00173}attP2 
 
S14 RasGAP1 
RNAi 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp} prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.GL01258}attP2 
 
S14 Son of 
Sevenless RNAi 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp} prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.HMS00149}attP2 
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S14 puckered 
RNAi 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp} prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.HMS01386}attP2 
 
S14 Rho kinase 
RNAi 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp} prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.HMS01311}attP2 
 
S14 Rho GAP1A 
RNAi 
w[*] / y[1] v[1]; 
+ / P{w[+mC] DC1.4-Flp} prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / P{y[+t7.7] v[+t1.8]=TRiP.HMS00267}attP2 
 
S14 Rho GAP190 
RNAi 
w[*] / y[1] v[1]; 
P{y[+t7.7] v[+t1.8]=TRiP.HMJ02052}attP40 / P{w[+mC] DC1.4-Flp} prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / + 
 
   
S16 prl-1 -/+ 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / CyO; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / TM2 
 
S16 prl-1 -/- + wt 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / p{w[+mC] UAS-HA.prl-1[wt]withUTRs}attP2 
 
S16 prl-1 -/- + prl-
1 G114E 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / p{w[+mC] UAS-HA.prl-1[G114E]withUTRs}attP2 
 
S16 prl-1 -/- + prl-
1 without UTRs 
w[*]; 
P{w[+mC] DC1.4-Flp} prl-1[2] / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / p{w[+mC] UAS-HA.prl-1[wt]noUTRs}attP2 
 
   
S17 control 
w[*]; 
+ / +; 
P{UAS-CD8::Cherry} P{GawB}pnrMD237 / P{w+UAS-PLCd-PH-EGFP} 
 
S17 prl-1 knock-
down 
w[*]; 
+ / +; 
P{TRiP.HMS01826}attP2 P{UAS-CD8::Cherry} P{GawB}pnrMD237 / P{w+UAS-PLCd-PH-EGFP} 
 
   
S18 control 
Either prl-1 heterozygous mutant or +/+ animals were used as controls, with same results: 
w[*]; 
+ / prl-1[2]; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 / P{w[+mC] DC1.4-Flp} P{GawB}pnrMD237 
or 
y[*] w[*] / w[*]; 
P{w[+mC] DC1.4-Flp} / +; 
p{w[+mC] UAS-FRT>STOP>FRT-CD8::GFP-2A-APEP-mCherry::Syt1}attp2 P{GawB}pnrMD237 / + 
 
